<unk>  is used only in combination therapy for the treatment of hepatitis C genotype 1, 3, or 4 infections; the agents used in combination, which include sofosbuvir, ribavirin, and interferon, vary based on the virus genotype, whether the person has cirrhosis and if a liver transplantation took place. It is not known whether<unk>  passes into breastmilk or has any effect on infants.
Daclatasvir
Balapiravir
Odalasvir
Telaprevir
Remdesivir
Favipiravir
Ledipasvir
Entecavir